Gene therapies for rare genetic diseases (Kyowa Kirin-owned; former NASDAQ biotech).
Gene therapies for rare genetic diseases (Kyowa Kirin-owned; former NASDAQ biotech).
- Stage
- Acquired
- Sector
- Health
Funding
Kyowa Kirinhistorical backers include Syncona
No open roles right now
Orchard Therapeutics isn’t hiring at the moment. Follow them and we’ll tell you when a role opens.
No photos or perks shared yet
Work at Orchard Therapeutics? Claim this basecamp to add photos, perks and how you work.
Claim it free
